Mandatory Disclaimers

Xeomin® (Incobotulinumtoxin A) 50, 100 Units is a Prescription Medicine. Indications: In adults, for the treatment of cervical dystonia; blepharospasm; spasticity of the upper limb; upper facial lines: glabellar frown lines, lateral periorbital lines (crow’s feet), horizontal forehead lines. Xeomin® has both risks and benefits, consult your doctor if Xeomin® is right for you. Further information on the risks and benefits of Xeomin® can be found in the Consumer Medicine Information (CMI) available from www.medsafe.govt.nz or by calling 0800 822 310. Use strictly as directed. If symptoms continue or you have side effects, see your doctor, pharmacist or health care professional. Common side effects include: Headaches; nausea; tenderness, swelling, redness, numbness or bruising of the skin; dry eye; heavy feeling of eyelid/ eyebrow/forehead; face/brow not symmetrical, dropping eyelids/eyebrows. Serious side effects are rare and include allergic reactions.

Dysport® is a prescription medicine containing Clostridium Botulinum Type A toxin complex for injection. It is used for the treatment of frown lines and excessive sweating. It should be administered only by trained medical professionals. Cautions: people with defective neuro-muscular transmission disorders, infection at site of injection, pregnancy and lactation. Possible side effects include headaches, pain, burning or redness at injection site, local muscle weakness including drooping eye lids, lack of feeling or nausea, or compensatory sweating in other skin areas. Talk to your specialist about the benefits/risks of this procedure. A charge applies. Dysport® treatment lasts about four months and after this time further courses of treatment may be necessary. Speak to your specialist about your own situation.

Sunekos 1200 is an implantable medical device that modifies the structure of mature skin, restoring volume, filling wrinkles and folds in the skin and in scar sites. It is suitable for creating a temporary increase in the volume of skin tissue. Sunekos 1200 is a medical device that is sterile, injectable, non-pyrogenic, biocompatible, re-absorbable, made with hyaluronic acid and amino acids.

Sunekos Performa is a medical device recommended for the treatment of blemishes and depressions in the skin caused by wrinkles and scars. Sunekos Performa is a sterile resorbable injectable solution which acts as a filler, supporting the restoration of physiological elasticity and temporarily replacing volume by expanding the soft tissues.

Sunekos should not be used on patients: with known hypersensitivity to any of its components; presenting with a general infection, inflammatory or infectious cutaneous problems; with history of severe multiple allergies or anaphylactic shock; prone to hypertrophic scars/keloids or streptococcal diseases; in patients presenting with porphyria; under 18 years of age; in pregnancy or lactation; others. See full instructions for use before prescribing for full safety information, available from www.xytide.co.nz

Copyright© 2024. Xytide Biotech Pty Ltd. Always read the label and follow the instructions. This medical device must be administered by a Healthcare Professional.

New Zealand Sponsor: AA-Med Pty Ltd.

Distributed by: Xytide Biotech NZ Pty Ltd (NZBN 9429049668612) C/O Alliott Ltd, Level 2, 142 Broadway, Newmarket, Auckland 1023 NZ. For more information please phone +61 1800 570 036

Profhilo®, containing low & high molecular weight hyaluronic acid, is a Class III medical device for the treatment of the face and body for contours redefinition and laxity remodelling where skin laxity is a problem. Profhilo® has risks and benefits. Do not use with treatments such a laser resurfacing or medium deep skin-peeling. Caution in people on blood thinning medicines. Do not inject into inflamed areas or intravenously or intramuscularly. Possible side effects: pain and swelling at injection site. Please refer to instructions for use, local distributor. Healthcare Logistics, Auckland.

To learn more about VISCODERM® HYDROBOOSTER go to www.ibsaderma.co.nz

VISCODERM® HYDROBOOSTER is a Class III medical device containing 25mg/1mL of cross-linked hyaluronic acid, it is used to restore intradermal hydration and to keep improve the structure and elasticity of the skin. VISCODERM® HYDROBOOSTER must only be administered by a medical practitioner or a qualified nurse injector (who operates under the supervision of a medical practitioner). Treatment costs and normal practitioner’s fees will apply. VISCODERM® HYDROBOOSTER has risks and benefits. If you have side effects or concerns, speak to your medical practitioner. Please consult your medical practitioner regarding its suitability for you. For further product information, please refer to your medical practitioner or the Instructions for Use leaflet at Dermocosmética PTY LTD, Australia.

Made in Italy. VISCODERM® HYDROBOOSTER is a registered trademark of IBSA. IBSA Farmaceutici S.r.l Via Martiri di Cefalonia 2 26900 Lodi – Italy. Distributed in New Zealand by Dermocosmética (NZBN 9429050049066) Suite A, Floor 8 Harbourview Building, 152 Quay St, Auckland Central, Auckland, New Zealand, through Healthcare Logistics. 58 Richard Pearse Drive, Airport Oaks, Manukau City, Auckland, New Zealand.

Copyright © Dermocosmetica 2024. All rights reserved. No part of this publication may be stored in a retrieval system or reproduced by any means whatsoever without written consent of the publisher.